Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Boothwyn Pharmacy LLC
WARNING LETTER
•Boothwyn Pharmacy LLC•June 9, 2025

Boothwyn Pharmacy LLC – FDA Warning Letter, Jun 9, 2025

Record Details

The FDA issued a Warning Letter to Boothwyn Pharmacy, LLC on January 16, 2026, stemming from an inspection conducted between May 12 and June 9, 2025. This inspection identified serious deficiencies in the company's drug production practices, posing significant patient safety risks. The primary violations cited involve drug products that were found to be adulterated and misbranded under the Federal Food, Drug, and Cosmetic Act (FDCA).

Key issues included insanitary conditions during the production of sterile drug products, such as inadequate smoke studies for ISO 5 areas and the presence of difficult-to-clean or particle-generating surfaces. The FDA also found multiple drug products to be subpotent, including Fluorescein 2% Ophthalmic Solution, Semaglutide 2.5mg/mL Injection, and Tirzepatide 10mg/mL Injection. Additionally, a Tirzepatide injection lot failed sterility testing, and several products were misbranded due to inaccurate strength labeling.

While Boothwyn Pharmacy initiated a voluntary recall and temporarily halted GLP-1 sterile drug production, the FDA found the proposed corrective actions insufficient. Specifically, the company failed to provide adequate documentation for new smoke studies and cleanroom renovations. Concerns were also raised about contradictory internal procedures regarding the "at-risk" release of sterile products before final test results and the lack of a clear process for notifying patients about out-of-specification results. The FDA requires Boothwyn Pharmacy to take prompt action, submitting a detailed written response within 15 working days outlining comprehensive corrective measures, root cause analyses, and supporting documentation. The agency strongly recommends engaging a third-party consultant with expertise in sterile drug manufacturing to conduct a thorough assessment of all operations, particularly aseptic processing. Non-compliance may lead to further legal action.

Company
Boothwyn Pharmacy LLC
Inspection date
June 9, 2025
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Matthew J. Lash (Acting Director)
  • John Howell
View Company Profile

ID · e91fc7a8-fe0b-4357-bcef-b628017d6f0a

Violation Codes10
21 U.S.C. 351(a)(2)(B)FD&C Act 501(a)(2)(B)FD&C Act 502(f)(1)FD&C Act 50521 U.S.C. 352(f)(1)21.U.S.C. 355(a)FD&C Act 501(a)(2)(A)FD&C Act 501(b)21 U.S.C. 351(b)FD&C Act 501(c)

Full citation text and observation details available on the Dashboard.

Other documents for Boothwyn Pharmacy LLC
  • 483 - 2025-06-10June 10, 2025
  • WARNING_LETTER - 2024-10-22October 22, 2024
  • 483 - 2024-10-22October 22, 2024
  • 483 - 2023-08-29August 29, 2023
  • 483 - 2021-09-08September 8, 2021

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Boothwyn Pharmacy LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.